Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.[2] In 2023, the company’s seat in Forbes Global 2000 was 89.[3]
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines (it is the world's largest producer of the last through its subsidiary Sanofi Pasteur).[4]
^"Annual Report 2023 (Form 20-F)". U.S. Securities and Exchange Commission. 23 February 2024.
^"Börse Frankfurt (Frankfurt Stock Exchange): Stock market quotes, charts and news". boerse-frankfurt.de. Archived from the original on 8 February 2019. Retrieved 23 May 2017.
^"The Global 2000 2023". Forbes. Archived from the original on 29 January 2024. Retrieved 7 February 2024.
^"Sanofi-Aventis to sign deal to build flu vaccine plant in China – source". Forbes. 23 November 2007. Retrieved 19 April 2009.[dead link]
with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product...
8437°E / 45.727; 4.8437 Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest...
With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group. The company...
innovators. In February 2022, Sanofi's new corporate brand was unveiled and former entity "Sanofi Genzyme" got integrated into Sanofi. The company was started...
cell called eosinophils. It was developed by Regeneron Pharmaceuticals and Sanofi Genzyme. It received approval from the US Food and Drug Administration (FDA)...
inflammation.[citation needed] On March 26, 2012, Bloomberg announced that Sanofi and Regeneron were in development of a new drug that would help reduce cholesterol...
2020" (PDF). "Sanofi Form 20-F 2019" (PDF). "Sanofi Form 20-F 2018" (PDF). "Sanofi Form 20-F 2017" (PDF). "Sanofi Form 20-F 2016" (PDF). "Sanofi Form 20-F...
November 2021 through a $180 million investment from French biopharma company Sanofi. Owkin uses federated learning, a decentralized machine learning technique...
No-Spa, distributed by the Hungarian plant Chinoin (owned by Sanofi). It is distributed by Sanofi as Но-Шпа (No-shpa) in Russia. Drotaverine hydrochloride...
firm Advent International; it was formerly, since 2008, a subsidiary of Sanofi. The roots of the Czech pharmaceutical company date back to 1488 with At...
December 2022. CYD-TDV, sold under the brand name Dengvaxia and made by Sanofi Pasteur, is a live attenuated tetravalent vaccine that is administered as...
history 2008–2010 2011 2011–2012 2013– Team Type 1 (TT1) Team Type 1–Sanofi Aventis (TT1) Team Type 1–Sanofi (TT1) Team Novo Nordisk (TNN) Current season...
It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and...
Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent...
Elf Sanofi (now known as Sanofi). In June 1994, Eastman Kodak sold the prescription drug business of its Sterling Winthrop subsidiary to Sanofi for US$1...
various brand names. It was developed by Sanofi Research (part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under...
barring Regeneron and Sanofi from marketing alirocumab, which was granted in January 2017. The judge gave Regeneron and Sanofi 30 days to appeal before...
approved for use in the United States in December 1999. Insulin lispro Sanofi was granted marketing authorization as a biosimilar in the European Union...
June 2016, the company announced it had struck an asset-swap deal with Sanofi, Boehringer would sell its consumer health division (valuing it at €6.7...
Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of...
President for Global Research and Development at the pharmaceutical company Sanofi. A resident of Pasadena, Maryland, Zerhouni was born in Nedroma, Algeria...
Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. The program was stopped when Sanofi Pasteur advised the government that...
Global Information
€43.07 billion (2023)
€7.875 billion (2023)